HOOKIPA PHARMA INC (HOOK)

US43906K1007 - Common Stock

6.14  +0.64 (+11.64%)

After market: 6.15 +0.01 (+0.16%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

HOOKIPA PHARMA INC

NASDAQ:HOOK (7/11/2024, 7:00:01 PM)

After market: 6.15 +0.01 (+0.16%)

6.14

+0.64 (+11.64%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month702.72%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap607.55M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

HOOK Daily chart

Company Profile

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The company is headquartered in New York City, New York and currently employs 156 full-time employees. The company went IPO on 2019-04-18. The firm is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology portfolio includes three disclosed programs, HB-200, HB-300 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-300 is in development for the treatment of prostate cancer and is in an ongoing Phase II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers.

Company Info

HOOKIPA PHARMA INC

The Empire State Building, 350 Fifth Avenue, Room/Suite 7240

New York City NEW YORK 10118

P: 114318906360

CEO: Joern Aldag

Employees: 156

Website: https://www.hookipapharma.com/

HOOK News

ChartMill News Imagea day ago - ChartmillWhat's going on in today's session

Top movers analysis one hour before the close of the markets on 2024-07-10: top gainers and losers in today's session.

ChartMill News Imagea day ago - ChartmillTop movers in Wednesday's session

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

ChartMill News Image2 days ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

News Image4 days ago - HOOKIPA Pharma Inc.HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
News Image4 days ago - HOOKIPA Pharma Inc.HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split

NEW YORK and VIENNA, July 08, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a company developing a new class of...

News Image10 days ago - HOOKIPA Pharma Inc.HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV

HOOK Twits

Here you can normally see the latest stock twits on HOOK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example